- Home
- SVM vs AVDL Comparison
SVM vs AVDL Comparison
Compare SVM & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- AVDL
- Stock Information
- Founded
- SVM N/A
- AVDL 2015
- Country
- SVM Canada
- AVDL Ireland
- Employees
- SVM N/A
- AVDL N/A
- Industry
- SVM Precious Metals
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- AVDL Health Care
- Exchange
- SVM Nasdaq
- AVDL Nasdaq
- Market Cap
- SVM 769.7M
- AVDL 784.6M
- IPO Year
- SVM N/A
- AVDL 1996
- Fundamental
- Price
- SVM $3.88
- AVDL $8.01
- Analyst Decision
- SVM Strong Buy
- AVDL Strong Buy
- Analyst Count
- SVM 1
- AVDL 7
- Target Price
- SVM $5.10
- AVDL $18.86
- AVG Volume (30 Days)
- SVM 6.5M
- AVDL 894.2K
- Earning Date
- SVM 05-22-2025
- AVDL 03-03-2025
- Dividend Yield
- SVM 0.64%
- AVDL N/A
- EPS Growth
- SVM 104.66
- AVDL N/A
- EPS
- SVM 0.36
- AVDL N/A
- Revenue
- SVM $266,463,000.00
- AVDL $169,117,000.00
- Revenue This Year
- SVM $35.71
- AVDL $50.78
- Revenue Next Year
- SVM $10.92
- AVDL $32.44
- P/E Ratio
- SVM $11.87
- AVDL N/A
- Revenue Growth
- SVM 28.94
- AVDL 504.79
- 52 Week Low
- SVM $2.87
- AVDL $7.39
- 52 Week High
- SVM $5.32
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- SVM 50.54
- AVDL 43.64
- Support Level
- SVM $3.93
- AVDL $7.98
- Resistance Level
- SVM $4.22
- AVDL $8.68
- Average True Range (ATR)
- SVM 0.17
- AVDL 0.35
- MACD
- SVM -0.03
- AVDL -0.02
- Stochastic Oscillator
- SVM 31.75
- AVDL 33.81
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.